| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Hagedorn Research Institute Department of Cell Biology 2820 Gentofte, Denmark
GH and PRL stimulate proliferation and insulin
production of pancreatic ß-cells. Whereas GH- and PRL-regulated
transcription of the insulin gene in insulinoma cells has been shown to
depend on STAT5 (signal transducer and activator of transcription 5),
the signaling pathways involved in GH/PRL-induced ß-cell replication
are unknown. The roles of various signaling pathways in human GH
(hGH)-induced DNA synthesis were studied by analysis of the effect of
specific inhibitors in both the insulin-producing cell line, INS-1, and
in primary ß-cells. The mitogen-activated protein kinase kinase
(MEK)-inhibitor, PD98059, as well as the mitogen-activated protein
kinase p38 (MAPKp38) inhibitor, SB203580, partially inhibited hGH-
induced proliferation in INS-1 cells but had no significant effect
in primary ß-cells. Staurosporine, a protein kinase C (PKC) and
protein kinase A (PKA) inhibitor, blocked both basal and hGH-induced
proliferation in INS-1 cells, but had no inhibitory effect in primary
ß-cells. Wortmannin, a phosphatidylinositol 3-kinase (PI3K)
inhibitor, inhibited hGH-induced proliferation neither in INS-1 cells
nor in primary ß-cells, whereas the tyrosine kinase inhibitor,
genistein, completely inhibited hGH- induced proliferation in both
primary ß-cells and INS-1 cells. To analyze the possible role of
STAT5 in hGH-induced proliferation, a dominant negative STAT5 mutant,
STAT5
749, was expressed in INS-1 cells under the control of a
doxycycline- inducible promoter by stable transfection. Two clones
were found to exhibit dose-dependent, doxycycline-inducible expression
of STAT5
749 and suppression of hGH-stimulated transcriptional
activation of a STAT5-regulated PRL receptor (PRLR) promoter-reporter
construct. Furthermore, induction of STAT5
749 expression completely
inhibited hGH-induced DNA synthesis. Analysis of endogenous gene
expression revealed a doxycycline-dependent inhibition of
hGH-stimulated PRLR and cyclin D2 mRNA levels. Our results suggest that
GH/PRL-induced ß-cell proliferation is dependent on the Janus Kinase2
(JAK2)/STAT5 signaling pathway but not the MAPK, PI3K, and PKC
signaling pathways. Furthermore, the cell cycle regulator cyclin D2 may
be a crucial target gene for STAT5 in this process.
This article has been cited by other articles:
![]() |
M. Y. Donath, J. Storling, L. A. Berchtold, N. Billestrup, and T. Mandrup-Poulsen Cytokines and {beta}-Cell Biology: from Concept to Clinical Translation Endocr. Rev., May 1, 2008; 29(3): 334 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mziaut, S. Kersting, K.-P. Knoch, W.-H. Fan, M. Trajkovski, K. Erdmann, H. Bergert, F. Ehehalt, H.-D. Saeger, and M. Solimena ICA512 signaling enhances pancreatic -cell proliferation by regulating cyclins D through STATs PNAS, January 15, 2008; 105(2): 674 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J Weinhaus, L. E Stout, N. V Bhagroo, T C. Brelje, and R. L Sorenson Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy J. Endocrinol., June 1, 2007; 193(3): 367 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Arumugam, D. Fleenor, and M. Freemark Lactogenic and Somatogenic Hormones Regulate the Expression of Neuropeptide Y and Cocaine- and Amphetamine-Regulated Transcript in Rat Insulinoma (INS-1) Cells: Interactions with Glucose and Glucocorticoids Endocrinology, January 1, 2007; 148(1): 258 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jackerott, A. Moldrup, P. Thams, E. D. Galsgaard, J. Knudsen, Y. C. Lee, and J. H. Nielsen STAT5 Activity in Pancreatic {beta}-Cells Influences the Severity of Diabetes in Animal Models of Type 1 and 2 Diabetes. Diabetes, October 1, 2006; 55(10): 2705 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, Q. Zhang, A. Tengholm, and A. Sjoholm Involvement of JAK2 and Src kinase tyrosine phosphorylation in human growth hormone-stimulated increases in cytosolic free Ca2+ and insulin secretion Am J Physiol Cell Physiol, September 1, 2006; 291(3): C466 - C475. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N Friedrichsen, N. Neubauer, Y. C Lee, V. K Gram, N. Blume, J. S Petersen, J. H Nielsen, and A. Moldrup Stimulation of pancreatic {beta}-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J. Endocrinol., March 1, 2006; 188(3): 481 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Lindberg, S G Ronn, D Tornehave, H Richter, J A Hansen, J Romer, M Jackerott, and N Billestrup Regulation of pancreatic {beta}-cell mass and proliferation by SOCS-3 J. Mol. Endocrinol., October 1, 2005; 35(2): 231 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jensen, E. D Galsgaard, A. E Karlsen, Y. C Lee, and J. H Nielsen STAT5 activation by human GH protects insulin-producing cells against interleukin-1{beta}, interferon-{gamma} and tumour necrosis factor-{alpha}-induced apoptosis independent of nitric oxide production J. Endocrinol., October 1, 2005; 187(1): 25 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E C Amaral, D. A Cunha, G. F Anhe, M. Ueno, E. M Carneiro, L. A Velloso, S. Bordin, and A. C Boschero Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancy J. Endocrinol., December 1, 2004; 183(3): 469 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cui, G. Riedlinger, K. Miyoshi, W. Tang, C. Li, C.-X. Deng, G. W. Robinson, and L. Hennighausen Inactivation of Stat5 in Mouse Mammary Epithelium during Pregnancy Reveals Distinct Functions in Cell Proliferation, Survival, and Differentiation Mol. Cell. Biol., September 15, 2004; 24(18): 8037 - 8047. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Brelje, L. E. Stout, N. V. Bhagroo, and R. L. Sorenson Distinctive Roles for Prolactin and Growth Hormone in the Activation of Signal Transducer and Activator of Transcription 5 in Pancreatic Islets of Langerhans Endocrinology, September 1, 2004; 145(9): 4162 - 4175. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Moon, E. D. Rubio, A. Martino, A. Krumm, and B. H. Nelson A Permissive Role for Phosphatidylinositol 3-Kinase in the Stat5- mediated Expression of Cyclin D2 by the Interleukin-2 Receptor J. Biol. Chem., February 13, 2004; 279(7): 5520 - 5527. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Friedrichsen, H. E. Richter, J. A. Hansen, C. J. Rhodes, J. H. Nielsen, N. Billestrup, and A. Moldrup Signal Transducer and Activator of Transcription 5 Activation Is Sufficient to Drive Transcriptional Induction of Cyclin D2 Gene and Proliferation of Rat Pancreatic {beta}-Cells Mol. Endocrinol., May 1, 2003; 17(5): 945 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Ronn, J. A. Hansen, K. Lindberg, A. E. Karlsen, and N. Billestrup The Effect of Suppressor of Cytokine Signaling 3 on GH Signaling in {beta}-Cells Mol. Endocrinol., September 1, 2002; 16(9): 2124 - 2134. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Graichen, D. Liu, Y. Sun, K.-O. Lee, and P. E. Lobie Autocrine Human Growth Hormone Inhibits Placental Transforming Growth Factor-beta Gene Transcription to Prevent Apoptosis and Allow Cell Cycle Progression of Human Mammary Carcinoma Cells J. Biol. Chem., July 12, 2002; 277(29): 26662 - 26672. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Yang, K. Yamagata, K. Fukui, Y. Cao, T. Nammo, H. Iwahashi, H. Wang, I. Matsumura, T. Hanafusa, R. Bucala, et al. Hepatocyte Nuclear Factor-1{alpha} Modulates Pancreatic {beta}-Cell Growth by Regulating the Expression of Insulin-Like Growth Factor-1 in INS-1 Cells Diabetes, June 1, 2002; 51(6): 1785 - 1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Brelje, A. M. Svensson, L. E. Stout, N. V. Bhagroo, and R. L. Sorenson An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans J. Histochem. Cytochem., March 1, 2002; 50(3): 365 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Trumper, K. Trumper, H. Trusheim, R. Arnold, B. Goke, and D. Horsch Glucose-Dependent Insulinotropic Polypeptide Is a Growth Factor for {beta} (INS-1) Cells by Pleiotropic Signaling Mol. Endocrinol., September 1, 2001; 15(9): 1559 - 1570. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |